Reliance Jio and the National Stock Exchange are poised to file draft IPO papers this week, targeting a combined fundraising of approximate...

Two asset managers are seeking regulatory approval for new ETFs tied to the "MANGOS" acronym, a basket of leading AI-focused companies incl...

Zydus Lifesciences' shares dipped 2% after completing the $166.4 million acquisition of US-based Assertio Holdings Inc. The deal, finalized...

A former Citigroup executive claims she was fired in retaliation for flagging regulatory and compliance risks. The lawsuit alleges these co...

The company has successfully completed the cash tender offer, through wholly-owned subsidiary, Zara Merger Sub Inc, for all the outstanding...

Indian pharma is shifting from generics to innovation. This transformation, extending to 2035, is creating significant new opportunities. C...

The long-awaited NSE IPO could move a step closer this week, with the exchange expected to file its draft papers with Sebi by Friday. Value...

In a landmark deal, Embassy Developments has entrusted Leighton Asia with a contract worth over Rs 850 crore for the construction of Embass...

Fintech firm Razorpay is preparing for its stock market debut. The company has confidentially filed for an initial public offering. Razorpa...

The Securities and Exchange Board of India has approached the Supreme Court. This follows a Securities Appellate Tribunal order that provid...

Several states have constituted dedicated multi-member teams to ensure no facility slips through the cracks before a GMP Certificate is iss...

Indian pharma stocks are outperforming the market, offering strong returns to investors. This resilience is driven by robust domestic deman...

India's income tax administration has become increasingly data-driven, with information from TDS/TCS reporting, SFT filings and other sourc...

Hyderabad's Hetero Labs partners with European giant Gedeon Richter. They will jointly develop and sell Semaglutide Injection, the generic ...

A promoter entity of Ajanta Pharma sold shares worth over Rs 1,024 crore through a block deal, with Kotak Mahindra Mutual Fund and Aditya B...

State Bank of India is set to commit up to $1 billion to fund Sun Pharmaceutical Industries Ltd.'s $12 billion acquisition of Organon & Co....

The Delhi High Court division bench has ruled in favor of Intas Pharmaceuticals, allowing the company to introduce its anti-cancer medicati...